Nanolute

Nanolute - Sirolimus Coated Balloon- MagicTouch PTA

Technology

Nanolute Technolgy - Concept Medical

Advantages of Nanolute Technology

SIROLIMUS DISTRIBUTION STUDY

1 HR

Intima

60-70% above IEL

DAY 3

Media

30-40% within Media

DAY 7

Adventitia

30-40% below IEL

Improves Lipophilicity of Sirolimus

  • Lipophilicity is the ability of a drug to dissolve in fats, oils, and lipids.
  • Sirolimus possesses poor lipophilicity and hence requires phospholipids.
  • NANOLUTE technology delivers polymer-free nanocarriers containing sirolimus surrounded by an encapsulation of a proprietary drug carrier, i.e., a phospholipid, and improves lipophilicity.

Solving Paclitaxel’s shortcomings

  • Lower Toxicity, Proven Safety
  • Stable Coating & Minimal Shedding
  • Less Embolization & Safer Procedures
  • Optimized Drug Retention & Delivery

The Game Changer Sirolimus Coated Balloon